O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.86B
AUM Growth
+$1.15B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
137
New
Increased
Reduced
Closed

Top Buys

1
+$186M
2
+$115M
3
+$60.8M
4
ABBV icon
AbbVie
ABBV
+$53.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.4M

Top Sells

1
+$83.2M
2
+$60M
3
+$58.4M
4
UNH icon
UnitedHealth
UNH
+$56.5M
5
CELG
Celgene Corp
CELG
+$53.8M

Sector Composition

1 Healthcare 86.06%
2 Technology 0.09%
3 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$26.9M 0.33%
2,113,000
-566,216
52
$26.8M 0.33%
1,893,000
-3,096,300
53
$25M 0.31%
+847,800
54
$24.8M 0.31%
957,700
55
$24.3M 0.3%
1,274,332
56
$24M 0.3%
1,785,714
57
$21.7M 0.27%
+830,100
58
$21.4M 0.26%
96,225
-3,250
59
$21.1M 0.26%
+1,075,400
60
$20.3M 0.25%
4,238,000
+863,000
61
$19.9M 0.24%
323,000
62
$18.7M 0.23%
267,000
+36,700
63
$17.5M 0.22%
133,000
-24,000
64
$16M 0.2%
+257,298
65
$15.9M 0.2%
115,000
66
$13.7M 0.17%
491,897
67
$13.6M 0.17%
1,490,769
68
$13.3M 0.16%
+1,292,027
69
$13.3M 0.16%
+83,063
70
$12.7M 0.16%
121,850
-19,631
71
$12.1M 0.15%
+316,000
72
$11.8M 0.15%
+100,000
73
$11.8M 0.15%
1,637,500
74
$11.8M 0.14%
219,850
-12,230
75
$11.7M 0.14%
5,702,000
1 2
3
4 5